Recon: Drug shortages climbed to record high in Q4; Vertex to acquire Alpine Immune for nearly $5 billion
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States